Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
428.78
422.33
337.33
374.14
338.23
333.37
252.33
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
428.78
422.33
337.33
374.14
338.23
333.37
252.33
Raw Material Cost
146.80
136.06
108.09
127.69
99.83
85.51
52.76
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
133.62
128.95
114.63
114.70
98.47
84.38
62.19
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
1.46
1.09
0.45
0.35
0.19
0.50
0.31
Selling and Distribution Expenses
151.23
137.02
122.40
112.75
96.91
89.29
75.71
Other Expenses
-7.82
-7.60
-6.04
-7.58
-6.30
-4.51
-3.77
Total Expenditure (Excl Depreciation)
354.91
327.08
285.20
279.65
232.43
214.62
153.30
Operating Profit (PBDIT) excl Other Income
73.89999999999999
95.19999999999999
52.1
94.5
105.8
118.80000000000001
99
Other Income
29.96
33.02
36.04
42.09
16.59
7.46
5.62
Operating Profit (PBDIT)
142.81
164.86
121.75
163.78
142.98
144.81
118.53
Interest
1.46
1.09
0.45
0.35
0.19
0.50
0.31
Exceptional Items
-0.67
-8.78
0.66
0.03
0.01
0.01
0.00
Gross Profit (PBDT)
281.98
286.26
229.24
246.45
238.40
247.87
199.57
Depreciation
31.98
29.01
20.13
17.61
13.10
7.22
3.28
Profit Before Tax
108.71
126.00
101.82
145.85
129.70
137.09
114.94
Tax
6.52
16.23
9.00
16.61
10.04
16.57
10.25
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
102.63
101.58
89.82
121.68
118.38
121.93
106.06
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
102.63
101.58
89.82
121.68
118.38
121.93
106.06
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
-2.80
7.32
2.67
7.60
1.31
-0.58
-0.49
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
99.83
108.90
92.48
129.29
119.70
121.36
105.57
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
1,345.15
1,312.20
1,345.78
1,350.18
363.50
240.42
153.81
Earnings per share (EPS)
1.03
1.02
0.89
1.22
1.18
1.22
1.06
Diluted Earnings per share
1.03
1.02
0.89
1.22
1.18
1.22
1.06
Operating Profit Margin (Excl OI)
18.86%
24.35%
19.44%
27.82%
33.49%
39.03%
43.45%
Gross Profit Margin
32.81%
36.7%
36.15%
43.69%
42.22%
43.29%
46.85%
PAT Margin
23.94%
24.05%
26.63%
32.52%
35.0%
36.58%
42.03%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
Net Sales
YoY Growth in year ended Dec 2025 is 1.54% vs 25.20% in Dec 2024
Consolidate Net Profit
YoY Growth in year ended Dec 2025 is -8.36% vs 17.73% in Dec 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Dec 2025 is -14.42% vs 53.79% in Dec 2024
Interest
YoY Growth in year ended Dec 2025 is 36.36% vs 120.00% in Dec 2024
Operating Profit Margin (Excl OI)
YoY Growth in year ended Dec 2025 has fallen from Dec 2024
Compare Annual Results Of Nanjing Medlander Medical Technology Co., Ltd. With
Figures in Million
Consolidate Annual Results
Change(CNY)
Change(%)
Net Sales
428.78
0
428.78
Other Operating Income
0.00
0.00
0.00
Total Operating income
428.78
0
428.78
Raw Material Cost
146.80
0
146.80
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
133.62
0
133.62
Power Cost
0
0
0.00
Manufacturing Expenses
1.46
0
1.46
Selling and Distribution Expenses
151.23
0
151.23
Other Expenses
-7.82
0.00
-7.82
Total Expenditure (Excl Depreciation)
354.91
0
354.91
Operating Profit (PBDIT) excl Other Income
73.88
0.00
73.88
Other Income
29.96
0
29.96
Operating Profit (PBDIT)
142.81
0
142.81
Interest
1.46
0
1.46
Exceptional Items
-0.67
0
-0.67
Gross Profit (PBDT)
281.98
0
281.98
Depreciation
31.98
0
31.98
Profit Before Tax
108.71
0
108.71
Tax
6.52
0
6.52
Provisions and contingencies
0
0
0.00
Profit After Tax
102.63
0
102.63
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
102.63
0
102.63
Share in Profit of Associates
0
0
0.00
Minority Interest
-2.80
0
-2.80
Other related items
0.00
0.00
0.00
Consolidated Net Profit
99.83
0
99.83
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
1,345.15
0
1,345.15
Earnings per share (EPS)
1.03
0
1.03
Diluted Earnings per share
1.03
0
1.03
Operating Profit Margin (Excl OI)
18.86%
0%
0.00
18.86%
Gross Profit Margin
32.81%
0%
0.00
32.81%
PAT Margin
23.94%
0%
0.00
23.94%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 42.88 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 1.54% vs 25.20% in Dec 2024
Annual - Consolidate Net Profit
Consolidate Net Profit 9.98 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -8.36% vs 17.73% in Dec 2024
Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 11.28 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is -14.42% vs 53.79% in Dec 2024
Annual - Interest
Interest 0.15 Million
in Dec 2025Figures in Million
YoY Growth in year ended Dec 2025 is 36.36% vs 120.00% in Dec 2024
Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.86%
in Dec 2025Figures in %
YoY Growth in year ended Dec 2025 has fallen from Dec 2024






